NCT04518501 2024-12-04
Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT06383078 2024-04-25
HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Not yet recruiting
NCT04284215 2020-02-25
Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC
Guizhou Medical University
Phase NA Unknown
NCT03660761 2019-04-16
Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors
Shandong Cancer Hospital and Institute
Phase 2 Completed
NCT03255343 2017-08-21
ImDendrim
French Association for the Advancement Medical Research
Phase NA Unknown